Skip to content

Locomotor Training in Persons With Multiple Sclerosis

Robotic Locomotor Training in Persons With Multiple Sclerosis

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00607126
Enrollment
38
Registered
2008-02-05
Start date
2006-07-31
Completion date
2009-08-31
Last updated
2016-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

impaired ambulation

Brief summary

Locomotor training is a new exercise modality that emphasizes task specificity to promote learning and neural plasticity. It has been reported to improve walking in patients with stroke, spinal cord injury and cerebral palsy. In this study, 40 patients with impaired ambulation due to Multiple Sclerosis will be randomized to receive 36 sessions of either locomotor training or an standard resistive exercise intervention.The locomotor training will be accomplished via a robotic device, the Lokomat, which will move the patient's legs on a treadmill while they are suspended in a harness.

Detailed description

In this study, subjects with confirmed diagnosis of Multiple Sclerosis were randomized into one of two treatment arms. Subjects in the Lokomat arm trained on the Lokomat with a supervising physical therapist for 20-30 minutes/session 3 times/week. The Lokomat is a robotic exoskeleton which enables the subject to step on a moving treadmill. Subjects were suspended in a harness while in the Lokomat with full to partial body weight support as needed. After the training in the Lokomat, they practiced overground walking for 10 minutes. The other treatment arm had subjects engage in resistance training with weights and resistance elastic bands matched to the Lokomat group for intensity, duration and frequency. they did not practice overground walking. Primary outcome measure was speed to accomplish 25' timed walk.

Interventions

DEVICELokomat

locomotor training using body weight support on a treadmill

resistive training using theraband and/or weights

Sponsors

National Multiple Sclerosis Society
CollaboratorOTHER
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Persons with Secondary progressive or Primary Progressive Multiple Sclerosis who are ambulatory with difficulty and /or assistive device

Exclusion criteria

* Ataxia * Unable to ambulate * Within 3 months of exacerbation

Design outcomes

Primary

MeasureTime frameDescription
Walking Speed as Assessed by 25' Timed Walkat beginning,mid point, end and 12 weeks after interventionThis is the time needed for participant to walk 25 feet. Participant walks on a level surface. the walk from start to finish is timed with a stop watch three measures are done and the average value is entered.

Secondary

MeasureTime frameDescription
Distancebaseline, mid point, end and 12 weeks after trainingdistance assessed by 6 minute walk test
Fatiguebaseline, mid, completetion, 3 months postfatigue assessed by modified fatigue impact scale. This is a 21 item questionnaire which has a range from 0-84. Higher scores indicate more impact of fatigue on physical and cognitive functioning.
PASATbaseline, mid, completion, 3 months post trainingCognitive measure of attention and information processing speed. Score goes from 0-60 with higher number indicating better performance. Scores are expressed as mean chamge rfom baseline; negative numbers indicate worse performance

Countries

United States

Participant flow

Recruitment details

Prospective subjects were recruited from the MS clinic population of the UCLA Dep't/ of Neurology and from the general MS population in Los Angeles between 2007-2009. Recruitment flyers were approved by the UCLA Institutional Review board.

Pre-assignment details

38 subjects were consented and randomized; two subjects volitionally dropped out before participating in the study; this accounts for the discrepancy..

Participants by arm

ArmCount
Lokomat Training Using Body Weight Support on a Treadmill
Locomotor training using body weight support on a treadmill, using robotic device to provide locomotor training. Locomotor training will be done using the Lokomat device. The Lokomat device is a robotic exoskeleton which fits over the patient's legs while they are suspended in a harness over a standard treadmill. the patient is suspended over a treadmill while their legs are in the Lokomat, which moves the legs on the treadmill. Patient had to be ambulatory with or without an assistive device. The amount of body weight support is gradually increased or decreased as needed.Partients were also given feedback by the physical therapist while they were walking on the treadmill. Patients trained for 30-40 minutes per session, for 3X/week. The average speed of training was 2.4km.hr. After lokomat training, the patients practiced over ground walking with the therapist for 15 minutes after each session.
17
Resistive Training
resistive training using weights and therabands This group trained for the same amount of time as the Lokomat group, i.e.3X/week for 30-40 minutes per session. they used resistive weights and /or theraband resistive bands to accomplish training. Exercises were done in supine, lying sitting and standing positions. Large muscle groups in both upper and lower extremities were trained. Patients completed 3 sets of 8-12 reps of each exercise, and performed 8-10 different exercises in each session.
19
Total36

Baseline characteristics

CharacteristicLokomat Training Using Body Weight Support on a TreadmillResistive TrainingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
17 Participants19 Participants36 Participants
EDSS6.5 units on a scale6.0 units on a scale6.3 units on a scale
Region of Enrollment
United States
17 participants19 participants36 participants
Sex: Female, Male
Female
9 Participants14 Participants23 Participants
Sex: Female, Male
Male
8 Participants5 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 170 / 19
serious
Total, serious adverse events
0 / 170 / 19

Outcome results

Primary

Walking Speed as Assessed by 25' Timed Walk

This is the time needed for participant to walk 25 feet. Participant walks on a level surface. the walk from start to finish is timed with a stop watch three measures are done and the average value is entered.

Time frame: at beginning,mid point, end and 12 weeks after intervention

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat Training Using Body Weight Support on a TreadmillWalking Speed as Assessed by 25' Timed Walk25'TW post21.7 secondsStandard Deviation 16.7
Lokomat Training Using Body Weight Support on a TreadmillWalking Speed as Assessed by 25' Timed Walk25'TW end point19.4 secondsStandard Deviation 15.2
Lokomat Training Using Body Weight Support on a TreadmillWalking Speed as Assessed by 25' Timed Walk25TW baseline22.7 secondsStandard Deviation 17.6
Lokomat Training Using Body Weight Support on a TreadmillWalking Speed as Assessed by 25' Timed Walk25'TW midpoint23.9 secondsStandard Deviation 20.9
Resistive TrainingWalking Speed as Assessed by 25' Timed Walk25'TW midpoint9.8 secondsStandard Deviation 4.3
Resistive TrainingWalking Speed as Assessed by 25' Timed Walk25TW baseline10.6 secondsStandard Deviation 4.9
Resistive TrainingWalking Speed as Assessed by 25' Timed Walk25'TW end point9.6 secondsStandard Deviation 3.7
Resistive TrainingWalking Speed as Assessed by 25' Timed Walk25'TW post10.5 secondsStandard Deviation 4.3
Secondary

Distance

distance assessed by 6 minute walk test

Time frame: baseline, mid point, end and 12 weeks after training

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat Training Using Body Weight Support on a TreadmillDistance6 min walk baseline367 feetStandard Deviation 241
Lokomat Training Using Body Weight Support on a TreadmillDistance6 min walk midpoint474 feetStandard Deviation 354
Lokomat Training Using Body Weight Support on a TreadmillDistance6 minute walk end point436 feetStandard Deviation 288
Lokomat Training Using Body Weight Support on a TreadmillDistance6 minute walk post457 feetStandard Deviation 300.5
Resistive TrainingDistance6 minute walk post742 feetStandard Deviation 248.2
Resistive TrainingDistance6 min walk baseline753 feetStandard Deviation 232.3
Resistive TrainingDistance6 minute walk end point769 feetStandard Deviation 261.9
Resistive TrainingDistance6 min walk midpoint813 feetStandard Deviation 253.8
Secondary

Fatigue

fatigue assessed by modified fatigue impact scale. This is a 21 item questionnaire which has a range from 0-84. Higher scores indicate more impact of fatigue on physical and cognitive functioning.

Time frame: baseline, mid, completetion, 3 months post

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat Training Using Body Weight Support on a TreadmillFatigueMFIS baseline34.1 units on a scaleStandard Deviation 14.1
Lokomat Training Using Body Weight Support on a TreadmillFatigueMFIS mid point26.7 units on a scaleStandard Deviation 13.7
Lokomat Training Using Body Weight Support on a TreadmillFatigueMFIS end point26.8 units on a scaleStandard Deviation 16.6
Lokomat Training Using Body Weight Support on a TreadmillFatigueMFIS post27.4 units on a scaleStandard Deviation 19.8
Resistive TrainingFatigueMFIS post35.3 units on a scaleStandard Deviation 15.9
Resistive TrainingFatigueMFIS baseline37.7 units on a scaleStandard Deviation 15.6
Resistive TrainingFatigueMFIS end point29.9 units on a scaleStandard Deviation 17.7
Resistive TrainingFatigueMFIS mid point29.4 units on a scaleStandard Deviation 15
Secondary

PASAT

Cognitive measure of attention and information processing speed. Score goes from 0-60 with higher number indicating better performance. Scores are expressed as mean chamge rfom baseline; negative numbers indicate worse performance

Time frame: baseline, mid, completion, 3 months post training

ArmMeasureGroupValue (MEAN)Dispersion
Lokomat Training Using Body Weight Support on a TreadmillPASATPASAT Mid point0.06 units on a scaleStandard Error 1.17
Lokomat Training Using Body Weight Support on a TreadmillPASATPASAT baseline48.2 units on a scaleStandard Error 5.1
Lokomat Training Using Body Weight Support on a TreadmillPASATPASAT post1.90 units on a scaleStandard Error 1.13
Lokomat Training Using Body Weight Support on a TreadmillPASATPASAT end point1.3 units on a scaleStandard Error 1.13
Resistive TrainingPASATPASAT post-0.91 units on a scaleStandard Error 1.13
Resistive TrainingPASATPASAT baseline46.8 units on a scaleStandard Error 3.8
Resistive TrainingPASATPASAT end point0.58 units on a scaleStandard Error 1.03
Resistive TrainingPASATPASAT Mid point0.42 units on a scaleStandard Error 1.03

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026